Counseling Points - January 2009 - (Page 2)

Faculty: Rebecca Albury, CRNP Pediatric Nurse Practitioner Center for Development and Learning Kennedy Krieger Institute Baltimore, Maryland Linda Rousseau, PMH-NP Psychiatric and Mental Health Nurse Practitioner Private Practice Scarborough, Maine Tsz-Yin So, PharmD, BCPS Pediatric Clinical Pharmacy Specialist Moses H. Cone Memorial Hospital Greensboro, North Carolina University of North Carolina Hospitals Chapel Hill, North Carolina Faculty Disclosure Statements Rebecca Albury, Linda Rousseau, and Tsz-Yin So have no conflicts of interest to report. Publishing Information: Publishers Joseph J. D’Onofrio Frank M. Marino Delaware Media Group 66 South Maple Avenue Ridgewood, NJ 07450 Tel: 201-612-7676 Fax: 201-612-8282 Website: www.delmedgroup.com Editorial Director Nancy Monson Art Director James Ticchio Cover photo credit: ©MedicalRF.com/Getty Images Copyright ©2009 National Association of Pediatric Nurse Practitioners, American Psychiatric Nurses Association, Delaware Media Group, LLC. Published by Delaware Media Group. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this publication are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, APNA, NAPNAP, or McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC. Counseling Points™ Caring for Individuals with ADHD Throughout the Lifespan: Pharmacologic Treatment Strategies for Children, Adolescents, and Adults with ADHD Continuing Education Information Target Audience This educational activity is designed to educate psychiatric nurses and family and pediatric nurse practitioners about issues related to caring for individuals with attention deficit hyperactivity disorder (ADHD) throughout their lifespan. Learning Objectives Upon completion of this educational activity, the participant should be able to: • List the major categories of pharmacologic agents used in the treatment of children, adolescents, and adults with attention deficit hyperactivity disorder (ADHD) • Describe the pharmacokinetics, indications, contraindications, and adverse events profiles associated with these pharmacologic agents • State recommendations for drug titration, structured treatment interruptions, and drug abuse in children, adolescents, and adults with ADHD NAPNAP Disclaimer The National Association of Pediatric Nurse Practitioners’ (NAPNAP) approval of this activity or continuing education credit does not imply product endorsement. APNA Disclaimer The American Psychiatric Nurses Association (APNA) presents the information in Counseling PointsTM as a service to its members. While APNA makes every effort to present accurate and reliable information, Counseling PointsTM contains information created or otherwise provided by individuals or organizations independent of APNA. APNA is not responsible for and does not endorse, approve, or guarantee the accuracy of the information presented, and expressly disclaims all liability for damages of any kind arising out of use, reference to, or reliance on such information. Continuing Education Credit This program has been approved for 1.0 NAPNAP contact hours, of which 1.0 contains Pharmacology (Rx) content. Approved program #A10-09-E01. This program expires February 28, 2010. Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The APNA, NAPNAP, McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC, and Delaware Media Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the APNA, NAPNAP, McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by OrthoMcNeil Janssen Scientific Affairs, LLC, and Delaware Media Group. Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other healthcare professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities. COUNSELING POINTS™ 2 http://www.delmedgroup.com http://www.MedicalRF.com/Getty

Table of Contents Feed for the Digital Edition of Counseling Points - January 2009

Counseling Points - January 2009

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.